Beloteca, Inc. Relocates Lab & Corporate Headquarters In San Diego, California
05/12/2017
The new facility currently spans more than 3,500 square feet and will expand to over 6,000 square feet. The larger space allows Beloteca's to increase its in-house product development capabilities and hire more employees in formulation and analytical development.
Beloteca currently has an active development pipeline with more than 15 pharmaceutical products in various stages of development.
According to company officials, the unification of the headquarters and laboratories will provide increased communication and collaboration between development and the other departments resulting in more efficient development of products.
"We are excited to have found this new location as it will enable Beloteca to continue to grow and internalize development over the next several years," said Fred Defesche, CEO of Beloteca, Inc. "The new space is ideal because it allows us to acquire additional space after obtaining approval of our first products without being encumbered by excess expenses while we are in our startup phase,” he added.
Project Announcements
GE Aerospace Expands Muskegon County, Michigan, Operations
02/15/2026
Global Polymers Plans Charlestown, Indiana, Headquarters Operations
02/15/2026
British-Based ARM Inc. Expands Austin, Texas, Operations
02/15/2026
Becton, Dickinson and Company Expands Columbus, Nebraska, Operations
02/15/2026
Umbra Plans Reston, Virginia, Operations
02/15/2026
Davie Defense Expands Galveston-Port Arthur, Texas, Operations
02/15/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025